Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines

In this study, we used patient-specific and isogenic PARK2-induced pluripotent stem cells (iPSCs) to show that mutations in PARK2 alter neuronal proliferation. The percentage of TH(+) neurons was decreased in Parkinson’s disease (PD) patient-derived neurons carrying various mutations in PARK2 compar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Stem Cell Reports
Autores principales: Shaltouki, Atossa, Sivapatham, Renuka, Pei, Ying, Gerencser, Akos A., Momčilović, Olga, Rao, Mahendra S., Zeng, Xianmin
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4437475/
https://ncbi.nlm.nih.gov/pubmed/25843045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stemcr.2015.02.019
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares